Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand

References

• Adams-Sapper S, Diep BA, Perdreau-Remington F, Riley LW. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrobial Agents and Chemotherapy 57, 490–7, 2013 doi: 10.1128/AAC.01025-12
   PubMed Web of Science ®Google Scholar
• *Anonymous. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Fourth Edtn. Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2013
   Google Scholar
• Bogaerts P, Huang TD, Bouchahrouf W, Bauraing C, Berhin C, El Garch F, Glupczynski Y. Characterization of ESBL- and AmpC-producing Enterobacteriaceae from diseased companion animals in Europe. Microbial Drug Resistance 21, 643–50, 2015 doi: 10.1089/mdr.2014.0284
   PubMed Web of Science ®Google Scholar
• Borjesson S, Bengtsson B, Jernberg C, Englund S. Spread of extended-spectrum β-lactamase producing Escherichia coli isolates in Swedish broilers mediated by an incI plasmid carrying blaCTX-M-1. Acta Veterinaria Scandinavica 55, 3, 2013 doi: 10.1186/1751-0147-55-3
   Web of Science ®Google Scholar
• *Bush K. Evolution of β-lactamases: past, present, and future. In: Dougherty TJ, Pucci MJ (eds). Antibiotic Discovery and Development. Pp 427–53. Springer US, New York, NY, USA, 2012
   Google Scholar
• Bush K. The ABCD’s of β-lactamase nomenclature. Journal of Infection and Chemotherapy 19, 549–59, 2013 doi: 10.1007/s10156-013-0640-7
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA.  Updated functional classification of β-lactamases. Antimicrobial Agents and Chemotherapy 54, 969–76, 2010 doi: 10.1128/AAC.01009-09
   PubMed Web of Science ®Google Scholar
• Caroff N, Espaze E, Gautreau D, Richet H, Reynaud A. Analysis of the effects of –42 and –32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. Journal of Antimicrobial Chemotherapy 45, 783–8, 2000 doi: 10.1093/jac/45.6.783
   PubMed Web of Science ®Google Scholar
• Costa D, Poeta P, Saenz Y, Vinue L, Rojo-Bezares B, Jouini A, Zarazaga M, Rodrigues J, Torres C.  Detection of Escherichia coli harbouring extended-spectrum β-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal. Journal of Antimicrobial Chemotherapy 58, 1311–2, 2006 doi: 10.1093/jac/dkl415
   PubMed Web of Science ®Google Scholar
• Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study. The Journal of Pediatrics 163, 1417–21, 2013 doi: 10.1016/j.jpeds.2013.06.078
   PubMed Web of Science ®Google Scholar
• Dierikx CM, van Duijkeren E, Schoormans AHW, van Essen-Zandbergen A, Veldman K, Kant A, Huijsdens XW, van der Zwaluw K, Wagenaar JA, Mevius DJ. Occurrence and characteristics of extended-spectrum- β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses. Journal of Antimicrobial Chemotherapy 67, 1368–74, 2012 doi: 10.1093/jac/dks049
   PubMed Web of Science ®Google Scholar
• Drinkovic D, Morris AJ, Dyet K, Bakker S, Heffernan H. Plasmid-mediated AmpC β-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials. New Zealand Medical Journal 128, 50–9, 2015
   PubMedGoogle Scholar
• Galani I, Kontopidou F, Souli M, Rekatsina P-D, Koratzanis E, Deliolanis J, Giamarellou H. Colistin susceptibility testing by Etest and disk diffusion methods. International Journal of Antimicrobial Agents 31, 434–9, 2008 doi: 10.1016/j.ijantimicag.2008.01.011
   PubMed Web of Science ®Google Scholar
• Guo S, Wakeham D, Brouwers HJ, Cobbold RN, Abraham S, Mollinger JL, Johnson JR, Chapman TA, Gordon DM, Barrs VR, Trott DJ. Human-associated fluoroquinolone-resistant Escherichia coli clonal lineages, including ST354, isolated from canine feces and extraintestinal infections in Australia. Microbes and Infection 17, 266–74, 2015 doi: 10.1016/j.micinf.2014.12.016
   PubMed Web of Science ®Google Scholar
• *Heffernan H, Pope C, Carter P. Identification of Extended-Spectrum β-Lactamase Types, Plasmid Mediated AmpC β-Lactamases and Strains Among Urinary Escherichia coli and Klebsiella in New Zealand in 2006. https://surv.esr.cri.nz/PDF_surveillance/Antimicrobial/ESBL/ESBLIdentification_2006.pdf (accessed 11 November 2016). Institute of Environmental Science & Research Limited, Porirua, NZ, 2007
   Google Scholar
• Heffernan H, Woodhouse RE, Pope C, Blackmore TK. Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. International Journal of Antimicrobial Agents 34, 544–9, 2009 doi: 10.1016/j.ijantimicag.2009.07.014
   PubMed Web of Science ®Google Scholar
• *Heffernan H, Dyet K, Woodhouse R, Williamson D. Antimicrobial Susceptibility and Molecular Epidemiology of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae in New Zealand, 2013. https://surv.esr.cri.nz/PDF_surveillance/Antimicrobial/ESBL/Enhanced_ESBL_2013.pdf (accessed 21 November 2016). Insititute of Environmental Science & Research Limited, Porirua, NZ, 2014
   Google Scholar
• Jacoby GA. Mechanisms of resistance to quinolones. Clinical Infectious Diseases 41, S120–S6, 2005 doi: 10.1086/428052
   PubMed Web of Science ®Google Scholar
• Jeong SH, Bae IK, Kwon SB, Lee JH, Song JS, Jung HI, Sung KH, Jang SJ, Lee SH. Dissemination of transferable CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli in Korea. Journal of Applied Microbiology 98, 921–7, 2005 doi: 10.1111/j.1365-2672.2004.02526.x
   PubMed Web of Science ®Google Scholar
• Kliebe C, Nies B, Meyer J, Tolxdorff-Neutzling R, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 28, 302–7, 1985 doi: 10.1128/AAC.28.2.302
   PubMed Web of Science ®Google Scholar
• Liu X, Thungrat K, Boothe DM. Occurrence of OXA-48 carbapenemase and other β-lactamase genes in ESBL-producing multidrug resistant Escherichia coli from dogs and cats in the United States, 2009–2013. Frontiers in Microbiology 7, 1057, 2016
   PubMed Web of Science ®Google Scholar
• MacVane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. Journal of Hospital Medicine 9, 232–8, 2014 doi: 10.1002/jhm.2157
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection 18, 268–81, 2012 doi: 10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Nagao M, Iguchi M, Yagi T, Komori T, Fujita N, Yamamoto M, Matsushima A, Takakura S, Ichiyama S. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia. Clinical Microbiology and Infection 19, 161–8, 2013 doi: 10.1111/j.1469-0691.2012.03762.x
   PubMed Web of Science ®Google Scholar
• Nakai H, Hagihara M, Kato H, Hirai J, Nishiyama N, Koizumi Y, Sakanashi D, Suematsu H, Yamagishi Y, Mikamo H. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. Journal of Infection and Chemotherapy 22, 319–26, 2016 doi: 10.1016/j.jiac.2016.02.004
   PubMed Web of Science ®Google Scholar
• Nebbia P, Tramuta C, Odore R, Nucera D, Zanatta R, Robino P.  Genetic and phenotypic characterisation of Escherichia coli producing cefotaximase-type extended-spectrum β-lactamases: first evidence of the ST131 clone in cats with urinary infections in Italy. Journal of Feline Medicine and Surgery 16, 966–71, 2014 doi: 10.1177/1098612X14527103
   PubMed Web of Science ®Google Scholar
• Pérez-Pérez FJ, Hanson ND.  Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. Journal of Clinical Microbiology 40, 2153–62, 2002 doi: 10.1128/JCM.40.6.2153-2162.2002
   PubMed Web of Science ®Google Scholar
• Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. The Lancet Infectious Diseases 8, 159–66, 2008 doi: 10.1016/S1473-3099(08)70041-0
   PubMed Web of Science ®Google Scholar
• Pleydell EJ, Souphavanh K, Hill KE, French NP, Prattley DJ. Descriptive epidemiological study of the use of antimicrobial drugs by companion animal veterinarians in New Zealand. New Zealand Veterinary Journal 60, 115–22, 2012 doi: 10.1080/00480169.2011.643733
   PubMed Web of Science ®Google Scholar
• Rayamajhi N, Kang SG, Lee DY, Kang ML, Lee SI, Park KY, Lee HS, Yoo HS. Characterization of TEM-, SHV- and AmpC-type β-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine. International Journal of Food Microbiology 124, 183–7, 2008 doi: 10.1016/j.ijfoodmicro.2008.03.009
   PubMed Web of Science ®Google Scholar
• Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. Journal of Antimicrobial Chemotherapy 66, 1–14, 2011 doi: 10.1093/jac/dkq415
   PubMed Web of Science ®Google Scholar
• Rzewuska M, Stefanska I, Kizerwetter-Swida M, Chrobak-Chmiel D, Szczygielska P, Lesniak M, Binek M. Characterization of extended-spectrum β-lactamases produced by Escherichia coli strains isolated from dogs in Poland. Polish Journal of Microbiology 64, 285–8, 2015
   PubMed Web of Science ®Google Scholar
• Saladin M, Cao VTB, Lambert T, Donay J-L, Herrmann J-L, Ould-Hocine Z, Verdet C, Delisle F, Philippon A, Arlet G. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiology Letters 209, 161–8, 2002
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 49, 2137–9, 2005 doi: 10.1128/AAC.49.5.2137-2139.2005
   PubMed Web of Science ®Google Scholar
• Stegemann M, Passmore C, Sherington J, Lindeman C, Papp G, Weigel D, Skogerboe T. Antimicrobial activity and spectrum of cefovecin, a new extended-spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America. Antimicrobial Agents and Chemotherapy 50, 2286–92, 2006 doi: 10.1128/AAC.00077-06
   PubMed Web of Science ®Google Scholar
• van Hoek AH, Schouls L, van Santen MG, Florijn A, de Greeff SC, van Duijkeren E. Molecular characteristics of extended-spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community. PloS One 10, e0129085, 2015 doi: 10.1371/journal.pone.0129085
   Google Scholar
• Wedley AL, Maddox TW, Westgarth C, Coyne KP, Pinchbeck GL, Williams NJ, Dawson S. Prevalence of antimicrobial-resistant Escherichia coli in dogs in a cross-sectional, community-based study. Veterinary Record 168, 354, 2011 doi: 10.1136/vr.d1540
   PubMed Web of Science ®Google Scholar
• *Winn WC, Koneman EW. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. Sixth Edtn. Lippincott Williams & Wilkins, Baltimore, MD, USA, 2006.
   Google Scholar
• Winokur P, Canton R, Casellas J-M, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clinical Infectious Diseases 32, S94–S103, 2001 doi: 10.1086/320182
   PubMed Web of Science ®Google Scholar
• Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MCJ, Ochman H, Achtman M. Sex and virulence in Escherichia coli: an evolutionary perspective. Molecular Microbiology 60, 1136–51, 2006 doi: 10.1111/j.1365-2958.2006.05172.x
   PubMed Web of Science ®Google Scholar
• *Woodford N. Rapid characterization of β-lactamases by multiplex PCR. In: Gillespie SH, McHugh TD (eds). Antibiotic Resistance Protocols. Second Edtn. Pp 181–92. Humana Press, New York, NY, USA, 2010
   Google Scholar
• Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrobial Agents and Chemotherapy 53, 4472–82, 2009 doi: 10.1128/AAC.00688-09
   PubMed Web of Science ®Google Scholar
• Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Shibata N, Kato H, Shibayama K, Arakawa Y.  Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Journal of Clinical Microbiology 43, 2551–8, 2005 doi: 10.1128/JCM.43.6.2551-2558.2005
   PubMed Web of Science ®Google Scholar
• *Non-peer-reviewed
   Google Scholar